[Federal Register Volume 88, Number 58 (Monday, March 27, 2023)]
[Notices]
[Pages 18139-18140]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-06258]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2023-0019]
Advisory Committee to the Director, Centers for Disease Control
and Prevention
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting of
the Advisory Committee to the Director, Centers for Disease Control and
Prevention (ACD, CDC). This is a hybrid meeting, accessible both in
person and virtually (webcast live via the World Wide Web). It is open
to the public and limited only by the space available. Time will be
available for public comment.
DATES: The meeting will be held on May 11, 2023, from 9 a.m. to 3 p.m.,
EDT (times subject to change).
Written comments must be received on or before May 1, 2023.
ADDRESSES:
Meeting address: CDC Roybal Campus, Building 19, Room 247 and 248,
1600 Clifton Road NE, Atlanta, Georgia 30329-4027. The conference rooms
combine to accommodate approximately 60 people.
Please note that the meeting location, the CDC Roybal Campus, is a
federal facility and in-person access is limited to United States
citizens unless prior authorizations, taking up to 30 to 60 days, have
been made. Visitors must follow all directions for access to CDC
facilities. Directions for visitors to CDC, including safety
requirements related to COVID-19, are available at https://www.cdc.gov/screening/visitors.html.
Registration: You must register to attend this meeting in person.
If you wish to attend in person, please submit a request by email to
[email protected] or by telephone at (404) 718-5028 at least 5
business days in advance
[[Page 18140]]
of the meeting. No registration is required to view the meeting via the
World Wide Web. Information for accessing the webcast will be available
at https://www.cdc.gov/about/advisory-committee-director/.
Written comments: You may submit comments, identified by Docket No.
CDC-2023-0019, by either of the methods listed below. Do not submit
comments for the docket by email. CDC does not accept comments for the
docket by email.
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Bridget Richards, MPH, Centers for Disease Control
and Prevention, 1600 Clifton Road NE, Mailstop H21-10, Atlanta, Georgia
30329-4027. Attn: Docket No. CDC-2023-0019.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to https://www.regulations.gov, including any personal
information provided. For access to the docket to read background
documents or comments received, go to https://www.regulations.gov.
Written comments received in advance of the meeting will be included in
the official record of the meeting.
FOR FURTHER INFORMATION CONTACT: Bridget Richards, MPH, Office of the
Chief of Staff, Centers for Disease Control and Prevention, 1600
Clifton Road NE, Mailstop H21-10, Atlanta, Georgia 30329-4027;
Telephone: (404) 718-5028; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee to the Director, CDC, shall (1)
make recommendations to the Director regarding ways to prioritize the
activities of the agency in alignment with the CDC Strategic Plan
required under section 305(c); H.R. 2617-1252; (2) advise on ways to
achieve or improve performance metrics in relation to the CDC Strategic
Plan, and other relevant metrics, as appropriate; (3) provide advice
and recommendations on the development of the Strategic Plan, and any
subsequent updates, as appropriate; (4) advise on grant, cooperative
agreements, contracts, or other transactions, as applicable; (5)
provide other advice to the Director, as requested, to fulfill duties
under sections 301 and 311; and (6) appoint subcommittees. The
Committee recommends ways to prioritize CDC's activities, improve
results, and address health disparities. It also provides guidance to
help CDC work more effectively with its various private and public
sector constituents to make health protection a practical reality.
Matters To Be Considered: The agenda will include discussions
regarding CDC's current and future work in the following topic areas:
(1) communications; (2) laboratory quality; (3) global health; (4)
health equity; (5) response readiness; and (6) data and surveillance.
The ACD will hear reports from its workgroups on data and surveillance,
laboratory quality, and health equity topics. In addition, the ACD will
hear an update on communications, global health, and response
readiness. Agenda items are subject to change as priorities dictate.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and other supporting
materials, are part of the public record and are subject to public
disclosure. Comments will be posted on https://www.regulations.gov.
Therefore, do not include any information in your comment or supporting
materials that you consider confidential or inappropriate for public
disclosure. If you include your name, contact information, or other
information that identifies you in the body of your comments, that
information will be on public display. CDC will review all submissions
and may choose to redact, or withhold, submissions containing private
or proprietary information such as Social Security numbers, medical
information, inappropriate language, or duplicate/near duplicate
examples of a mass-mail campaign. CDC will carefully consider all
comments submitted into the docket.
Written Public Comment: The docket will be opened to receive
written comments on March 27, 2023 through April 28, 2023.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-06258 Filed 3-24-23; 8:45 am]
BILLING CODE 4163-18-P